• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gold Down Over 1%; FedEx Shares Rise On Earnings Beat

    9/21/23 12:07:28 PM ET
    $CSCO
    $CZOO
    $FDX
    $MURF
    Computer Communications Equipment
    Telecommunications
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary
    Get the next $CSCO alert in real time by email

    U.S. stocks traded lower midway through trading, with the Dow Jones falling around 150 points on Thursday.

    The Dow traded down 0.46% to 34,284.15 while the NASDAQ fell 1.05% to 13,327.80. The S&P 500 also fell, dropping, 0.95% to 4,360.19.

    Check This Out: McDonald's, Halliburton And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

    Information technology shares fell by just 0.5% on Thursday.

    In trading on Thursday, consumer discretionary shares tumbled by 1.9%.

     

    Top Headline

    FedEx Corp (NYSE:FDX) shares gained over 4% on Wednesday after the company reported better-than-expected earnings for its first quarter, while sales missed estimates. The company lowered its full-year revenue guidance, but raised its earnings outlook.

    FedEx reported first-quarter revenue of $21.7 billion, which missed the consensus estimate of $21.81 billion. The company reported quarterly earnings of $4.55 per share, which beat analyst estimates of $3.74 per share.

     

    Equities Trading UP

    Murphy Canyon Acquisition Corp. (NASDAQ:MURF) shares shot up 42% to $18.21. Murphy Canyon Acquisition reported stockholder approval of the proposed combination with Conduit Pharmaceuticals.

    Shares of Near Intelligence, Inc. (NASDAQ:NIR) got a boost, shooting 46% to $0.3061. Near Intelligence said it is a trusted partner of leading global commercial real estate companies seeking high-quality real estate analytics on any location, building or site.

    Splunk Inc. (NASDAQ:SPLK) shares were also up, gaining 21% to $144.78. Cisco Systems, Inc (NASDAQ:CSCO) agreed to acquire Splunk for $157 per share in cash, representing approximately $28 billion in equity value.

     

    Equities Trading DOWN

    Travere Therapeutics, Inc. (NASDAQ:TVTX) shares dropped 41% to $7.57 after the company announced topline two-year confirmatory secondary endpoint results from its head-to-head Phase 3 PROTECT Study of Filspari (sparsentan) in IgA nephropathy (IgAN) versus Sanofi SA's (NASDAQ:SNY) Avapro (irbesartan).

    Shares of Cazoo Group Ltd (NYSE:CZOO) were down 32% to $0.5375. Cazoo recently announced deleveraging plan with noteholders and shareholders, enhancing financial flexibility.

    Seelos Therapeutics, Inc. (NASDAQ:SEEL) was down, falling 33% to $0.2034 after the company announced a $4.5 million registered direct offering of common stock and warrants to purchase common stock. Guggenheim downgraded Seelos Therapeutics from Buy to Neutral.

    Also Check This Out: Top 4 Health Care Stocks That Should Keep You Up At Night

     

    Commodities

    In commodity news, oil traded up 0.9% to $90.46 while gold traded down 1.2% at $1,943.60.

    Silver traded down 0.7% to $23.66 on Thursday while copper fell 2.4% to $3.6855.

     

    Euro zone

    European shares were lower today. The eurozone’s STOXX 600 fell 1.04% London’s FTSE 100 fell 0.20% while Spain’s IBEX 35 Index fell 0.96% The German DAX fell 1.10% French CAC 40 declined 1.42%, while Italy’s FTSE MIB Index dipped 1.66%.

    The Bank of England maintained its policy interest rate at 5.25% on Sept. 21. Spain's trade deficit shrank to EUR 4.9 billion in July from EUR 6.56 billion in the year-ago month. Construction output in Italy fell by 1.1% year-over-year in July. The manufacturing climate indicator in France climbed to 99 in September versus a revised 97 in a month ago.

     

    Asia Pacific Markets

    Asian markets closed lower on Thursday, with Japan’s Nikkei 225 falling 1.37%, Hong Kong’s Hang Seng Index falling 1.29% and China’s Shanghai Composite Index falling 0.77%. India’s S&P BSE Sensex, meanwhile, declined 0.85%.

    The annual inflation rate in Hong Kong came in at 1.8% in August, remaining at its lowest level in four months. Hong Kong’s current account surplus increased to HKD 47.5 billion in the second quarter from HKD 34.7 billion in the year-ago period. The Hong Kong Monetary Authority kept its base rate unchanged at 5.75%.

     

    Economics

    U.S. initial jobless claims fell by 20,000 to 201,000 in the week ending Sept. 16, recording the lowest reading since late January and compared to market estimates of 225,000.

    The U.S. current account deficit shrank to $212.1 billion in the second quarter from a revised reading of a $214.5 billion gap in the prior period and compared to the market estimates of a $221.0 billion gap.

    The Philadelphia Fed Manufacturing Index declined to -13.5 in September from 12 in the previous month and worse than market expectations of -0.7.

    Existing-home sales in the U.S. fell0.7% from a month ago to an annualized rate of 4.04 million units in August.

    U.S. natural gas supplies rose 64 billion cubic feet last week, the EIA said.

    Now Read This: CrowdStrike Holdings To Rally Over 31%? Here Are 10 Other Analyst Forecasts For Thursday

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 108,530,790 cases with around 1,175,490 deaths. India confirmed a total of at least 44,998,290 cases and 531,930 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 695,580,070 cases of COVID-19 worldwide with more than 6,918,190 deaths.

    Get the next $CSCO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CSCO
    $CZOO
    $FDX
    $MURF

    CompanyDatePrice TargetRatingAnalyst
    FedEx Corporation
    $FDX
    2/13/2026$313.00 → $383.00Buy
    TD Cowen
    Sanofi
    $SNY
    2/12/2026Buy → Neutral
    BofA Securities
    FedEx Corporation
    $FDX
    2/3/2026$380.00Equal Weight → Overweight
    Wells Fargo
    FedEx Corporation
    $FDX
    2/3/2026$427.00Mkt Perform → Outperform
    Bernstein
    Sanofi
    $SNY
    1/27/2026Neutral
    Citigroup
    Cisco Systems Inc.
    $CSCO
    1/26/2026$100.00In-line → Outperform
    Evercore ISI
    FedEx Corporation
    $FDX
    1/21/2026$271.00Buy → Neutral
    Rothschild & Co Redburn
    Sanofi
    $SNY
    1/16/2026Buy → Neutral
    UBS
    More analyst ratings

    $CSCO
    $CZOO
    $FDX
    $MURF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Global Sales Tuszik Oliver covered exercise/tax liability with 3,695 shares, decreasing direct ownership by 2% to 191,745 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    2/11/26 8:44:07 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    SVP & Chief Acctg Officer Wong Maria Victoria covered exercise/tax liability with 1,191 shares, decreasing direct ownership by 4% to 31,037 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    2/11/26 8:46:09 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    EVP, Operations Subaiya Thimaya K. covered exercise/tax liability with 6,736 shares, decreasing direct ownership by 4% to 170,386 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    2/11/26 8:43:28 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $CSCO
    $CZOO
    $FDX
    $MURF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP CHIEF FINANCIAL OFF Dietrich John W bought $273,980 worth of shares (1,000 units at $273.98), increasing direct ownership by 12% to 9,067 units (SEC Form 4)

    4 - FEDEX CORP (0001048911) (Issuer)

    1/8/25 7:43:16 PM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    Director Lane Amy B bought $91,929 worth of shares (333 units at $276.06) (SEC Form 4)

    4 - FEDEX CORP (0001048911) (Issuer)

    12/26/24 5:08:58 PM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    Dietrich John W bought $252,020 worth of shares (1,000 units at $252.02), increasing direct ownership by 27% to 4,745 units (SEC Form 4)

    4 - FEDEX CORP (0001048911) (Issuer)

    12/28/23 4:16:47 PM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    $CSCO
    $CZOO
    $FDX
    $MURF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on FedEx with a new price target

    TD Cowen reiterated coverage of FedEx with a rating of Buy and set a new price target of $383.00 from $313.00 previously

    2/13/26 8:02:23 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    Sanofi downgraded by BofA Securities

    BofA Securities downgraded Sanofi from Buy to Neutral

    2/12/26 7:23:56 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FedEx upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded FedEx from Equal Weight to Overweight and set a new price target of $380.00

    2/3/26 6:49:32 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    $CSCO
    $CZOO
    $FDX
    $MURF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FedEx Joins Hedera Council to Support the Future of Digital Global Supply Chains

    Contributing the company's extensive operational expertise and perspective to support cooperative approaches to distributed infrastructure. MEMPHIS, Tenn., Feb. 13, 2026 /PRNewswire/ -- FedEx Corp. (NYSE:FDX) today announced joining Hedera Council, a governing body made up of leading global organizations dedicated to fostering trust, security, and innovation on the Hedera network. FedEx joins the Council to help advance trusted digital infrastructure that can support the evolving lifecycle of global shipments and make supply chains smarter for everyone. FedEx's participation i

    2/13/26 11:00:00 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    FedEx Corp. Board Declares Quarterly Dividend

    The Board of Directors of FedEx Corp. (NYSE:FDX) today declared a quarterly cash dividend of $1.45 per share on FedEx Corp. common stock, in line with the company's continued focus on delivering stockholder value. The dividend is payable April 1, 2026, to stockholders of record at the close of business on March 9, 2026. FedEx Corp. (NYSE:FDX) provides customers and businesses worldwide with a broad portfolio of transportation, e-commerce and business services. With annual revenue of $90 billion, the company offers integrated business solutions utilizing its flexible, efficient, and intelligent global network. Consistently ranked among the world's most admired and trusted employers, FedEx

    2/13/26 9:01:00 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results

    Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 19, 2026, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. The webcast and dial-in information can be accessed on the Investor page of Travere's website at https://ir.travere.com/events-and-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company's website. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a bi

    2/12/26 4:30:00 PM ET
    $TVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CSCO
    $CZOO
    $FDX
    $MURF
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 28, 2025 - FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

    For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

    3/28/25 10:17:55 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 14, 2025 - FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

    For Immediate Release: February 14, 2025 Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Meri

    2/14/25 3:00:13 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SOLIQUA 100/33 issued to SANOFI-AVENTIS US

    Submission status for SANOFI-AVENTIS US's drug SOLIQUA 100/33 (SUPPL-14) with active ingredient INSULIN GLARGINE; LIXISENATIDE has changed to 'Approval' on 11/01/2024. Application Category: BLA, Application Number: 208673, Application Classification:

    11/4/24 4:49:34 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CSCO
    $CZOO
    $FDX
    $MURF
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Travere Therapeutics Inc.

    SCHEDULE 13G/A - Travere Therapeutics, Inc. (0001438533) (Subject)

    2/13/26 6:13:14 AM ET
    $TVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Sanofi

    6-K - Sanofi (0001121404) (Filer)

    2/12/26 9:17:45 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cisco Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CISCO SYSTEMS, INC. (0000858877) (Filer)

    2/11/26 4:07:20 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $CSCO
    $CZOO
    $FDX
    $MURF
    Leadership Updates

    Live Leadership Updates

    View All

    FedEx Appoints Scott Ray as Chief Operating Officer for U.S. and Canada Surface Operations

    FedEx Corp. (NYSE:FDX) today announced the appointment of Scott Ray as chief operating officer for U.S. and Canada Surface Operations, effective June 1. He will begin transitioning into the role as COO-elect on Feb. 1. Reporting to FedEx President and CEO Raj Subramaniam, Ray will be the newest member of the FedEx Executive Committee, succeeding John Smith, who will transition to CEO of FedEx Freight as of June 1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126094399/en/FedEx appoints Scott Ray as chief operating officer of Surface Operations in U.S. and Canada Ray will be responsible for leading all aspects of Surface Ope

    1/27/26 8:31:00 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    FedEx Announces Board of Directors for Future Independent FedEx Freight

    Board includes veteran leaders with transportation and logistics, financial, and technology expertise FedEx Corp. (NYSE:FDX) today announced the ten-member board of directors for FedEx Freight, ahead of its planned spin-off from FedEx Corp. on June 1, 2026. As previously announced, R. Brad Martin, current executive chairman of the FedEx Corp. board of directors, will serve as chairman of the board of FedEx Freight. John Smith, the incoming president and chief executive officer of FedEx Freight, will also serve as a director, alongside eight other highly experienced leaders across the transportation and logistics, supply chain management, and technology sectors. "We've assembled a grou

    1/16/26 8:01:00 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    ITM Appoints Annette Breunig as Chief People Officer

    Global HR leader to drive ITM's long-term human resources strategy, support organizational development and corporate growth Garching / Munich, Germany, October 13, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the appointment of Annette Breunig as Chief People Officer (CPO). Ms. Breunig brings over 25 years of HR leadership experience at international pharmaceutical, manufacturing and technology companies, including at Siemens AG (FRA: SIE) and Sanofi (NASDAQ:SNY). At ITM, Ms. Breunig will lead the HR team in shaping strategies that unify the organization to achieve both team and business growth objectives while empowering em

    10/13/25 5:00:00 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CSCO
    $CZOO
    $FDX
    $MURF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.

    SC 13G/A - SEELOS THERAPEUTICS, INC. (0001017491) (Subject)

    12/4/24 1:29:12 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.

    SC 13G/A - SEELOS THERAPEUTICS, INC. (0001017491) (Subject)

    11/14/24 7:32:44 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Travere Therapeutics Inc.

    SC 13G/A - Travere Therapeutics, Inc. (0001438533) (Subject)

    11/14/24 5:13:38 PM ET
    $TVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CSCO
    $CZOO
    $FDX
    $MURF
    Financials

    Live finance-specific insights

    View All

    FedEx Corp. Board Declares Quarterly Dividend

    The Board of Directors of FedEx Corp. (NYSE:FDX) today declared a quarterly cash dividend of $1.45 per share on FedEx Corp. common stock, in line with the company's continued focus on delivering stockholder value. The dividend is payable April 1, 2026, to stockholders of record at the close of business on March 9, 2026. FedEx Corp. (NYSE:FDX) provides customers and businesses worldwide with a broad portfolio of transportation, e-commerce and business services. With annual revenue of $90 billion, the company offers integrated business solutions utilizing its flexible, efficient, and intelligent global network. Consistently ranked among the world's most admired and trusted employers, FedEx

    2/13/26 9:01:00 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results

    Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 19, 2026, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. The webcast and dial-in information can be accessed on the Investor page of Travere's website at https://ir.travere.com/events-and-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company's website. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a bi

    2/12/26 4:30:00 PM ET
    $TVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CISCO REPORTS SECOND QUARTER EARNINGS

    SAN JOSE, Calif., Feb. 11, 2026 /PRNewswire/ --  News Summary: Double-digit top and bottom-line growth exceeding our guidance, with EPS growing faster than revenueRecord revenue of $15.3 billion, up 10% year over year; GAAP EPS of $0.80, up 31% year over year; and Non-GAAP EPS of $1.04, up 11% year over yearGAAP gross margin of 65.0% and Non-GAAP gross margin of 67.5%; GAAP operating margin of 24.6% and Non-GAAP operating margin of 34.6%, both above the high end of our guidance rangeAccelerating, double-digit growth in product orders across all geographies and robust growth ac

    2/11/26 4:05:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications